tiprankstipranks
Trending News
More News >
iX Biopharma Ltd. (SG:42C)
:42C
Singapore Market
Advertisement

iX Biopharma Ltd. (42C) Revenue

Compare
10 Followers

iX Biopharma Ltd. Revenue

iX Biopharma Ltd. had a revenue of 2.03M in the quarter ending Jun 30, 2025, with 0.00%. This bring the company's revenue in the last twelve months to 7.77M, Decreased 5.19%. In the fiscal year ending Dec 31, 2024, iX Biopharma Ltd. had annual revenue of 7.77M with 30.34% growth.
Revenue (ttm)
7.77M
Revenue Growth
30.34%
P/S Ratio
13.39
Revenue/Employee
S$221,914
Employees
35
Market Cap
S$103.99M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
7.77M1.81M+130.34%
Dec 31, 2023
5.96M46.00K+100.78%
Dec 31, 2022
5.91M-8.48M+41.09%
Dec 31, 2021
14.39M12.64M+824.64%
Dec 31, 2020
1.75M760.00K+177.16%
Dec 31, 2019
985.00K314.00K+146.80%
Dec 31, 2018
671.00K425.00K+272.77%
Dec 31, 2017
246.00K-6.13M+3.86%
Dec 31, 2016
6.38M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis